Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-096989
Filing Date
2024-08-14
Accepted
2024-08-14 16:05:06
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4595
  Complete submission text file 0000950170-24-096989.txt   6095
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Issuer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SURFACE ONCOLOGY 50 HAMPSHIRE ST., 8TH FLOOR CAMBRIDGE MA 02139
Business Address
GRAYZEL DAVID S. (Reporting) CIK: 0001732786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38433 | Film No.: 241207446